The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clin Mol Hepatol. 2016;22(2):241-249. Published online 2016 Jun 15 DOI: https://doi.org/10.3350/cmh.2015.0053
Citations to this article as recorded by 
Switching from Tenofovir-Based Combination Therapy to Tenofovir Monotherapy in Multidrug-Experienced Chronic Hepatitis B Patients: a 5-Year Experience at Two Centers
Jung Hun Kim, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung-chul Yoo, Eileen L. Yoon, Seong Hee Kang
Antimicrobial Agents and Chemotherapy.2022;[Epub] CrossRef
Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg‐positive high viral load chronic hepatitis B
J. Y. Nam, Y. Chang, H. Cho, S. H. Kang, Y. Y. Cho, E. J. Cho, J.‐H. Lee, S. J. Yu, J.‐H. Yoon, Y. J. Kim
Journal of Viral Hepatitis.2018; 25(5): 552. CrossRef
Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015
Pengtao Liu, Lingjie Liao, Wei Xu, Jing Yan, Zhongbao Zuo, Xuebing Leng, Jing Wang, Wei Kan, Yinghui You, Hui Xing, Yuhua Ruan, Yiming Shao
Medicine.2018; 97(50): e13555. CrossRef
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Hyung Joon Yim
Clinical and Molecular Hepatology.2016; 22(2): 238. CrossRef